GlassScriptPhysician profile
Paul C Redman
NPI 1932100302
$1,791.07
in general payments reported to CMS, 2019-2025
23 companies · $60.95 in 2025
The $60.95 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $287 · 2021: $380 · 2022: $430 · 2023: $249 · 2024: $221 · 2025: $60.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $425.23 | 2019-2023 | |
| Myovant Sciences INC. | $193.73 | 2021-2022 | |
| Coloplast Corp | $184.85 | 2019-2021 | |
| Hologic Sales and Service, LLC | $143.96 | 2021-2024 | Aptima, Acessa Provu System, Novasure |
| Davol INC. | $104.20 | 2019-2022 | |
| Evofem Biosciences, INC. | $86.32 | 2021-2023 | Phexxi |
| Sumitomo Pharma America, INC. | $85.15 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $63.21 | 2020-2022 | |
| Coopersurgical, INC. | $58.06 | 2021-2025 | Advincula Delineator Uterine Manipulator |
| Pfizer INC. | $52.26 | 2024 | |
| Meditrina | $49.19 | 2024 | |
| Smith+Nephew, INC. | $48.86 | 2019-2021 | |
| Aspira Women'S Health INC | $46.75 | 2022-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $39.71 | 2021-2022 | |
| Kerecis Limited | $34.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $33.42 | 2023 | Slynd |
| Biogen, INC. | $26.41 | 2024 | |
| Organon LLC | $24.28 | 2022 | |
| Innovation Technologies INC | $21.36 | 2025 | Irrisept |
| Acessa Health INC. | $21.32 | 2020 | |
| Amag Pharmaceuticals, INC. | $17.68 | 2020 | |
| Duchesnay USA Incorporated | $16.75 | 2019 | |
| Kci USA, INC. | $14.29 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Redman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.